Rising incidence of cancer, infectious diseases, and genetic disorders; growth in funding for research on genomic, proteomic, and electrophoresis techniques; growing number of industry-academia research collaborations; growing use of capillary electrophoresis with mass spectroscopy; and growth in the number of clinical, forensic, and research laboratories are the major factors driving the growth of the electrophoresis market during the forecast period.
What the Market Looks Like?
Predicted to grow at a CAGR of 5.4% during the forecast period, the global Electrophoresis Market is estimated to reach USD 2.80 Billion by the end of 2022. In 2016, North America held the largest share of the global electrophoresis market, followed by Europe and Asia-Pacific. However, Asia-Pacific region is expected to witness the highest CAGR during the forecast period.
On the basis of product, the reagent segment accounted for the largest share of the global electrophoresis market. This is primarily attributed to the increasing demand for 2D electrophoresis for protein separation for various applications such as biomarker discovery and protein mapping. Over the years, genomic and proteomic technologies have gained significant importance in fields of clinical diagnosis and drug discovery and development. These are some of the key factors driving the growth of the electrophoresis market, and in turn supporting the growth of the electrophoresis reagents market during the forecast period.
Based on application, the research segment accounted for the largest share of this market. Low cost and sensitive approach for DNA sequencing, the major role of electrophoresis in drug discovery, rising use of electrophoresis techniques as a result of growing importance of antibody research in the development of biotherapeutic are the major factors driving the use of electrophoresis, which has boosted the demand for research applications.
Download PDF Brochure @
What Drives the Market?
The growth of the global market for Electrophoresis is primarily influenced by the following factors:
- Rising Incidence of Cancer, Infectious Diseases, and Genetic Disorders
- Growth in Funding for Research on Genomic, Proteomic, and Electrophoresis Techniques
- Growing Number of Industry-Academia Research Collaborations
- Growing Use of Capillary Electrophoresis With Mass Spectroscopy
- Growing Use of Next-Generation Sequencing
- Rapid Growth in Aging Population
- Growth in the Number of Clinical, Forensic, and Research Laboratories
Geographical growth scenario of Electrophoresis Market
North America accounted for the largest share of the electrophoresis market in 2016, followed by Europe and Asia-Pacific. The patent expiration of several blockbuster drugs of major pharmaceutical companies is, in turn, increasing investments for new drug discovery; this is a key market driver in North America. In addition, the growing focus of stakeholders on research projects involving proteins, associated biomolecules, and genes; stringent regulatory requirements regarding pharmaceutical manufacturing necessitating quality control and process validation processes; rising focus on the development of structure-based drug designs; and growing research activities in the fields of genomics and proteomics is attributed to the largest share of electrophoresis market in North America.
Download PDF Brochure @
Leading market players and strategies adopted
The prominent players in the Electrophoresis market include Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.). These companies adopted strategies like new product launches, acquisitions, collaborations, expansions, and other developments in order to achieve sustained growth and expand their global presence as well.